Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MD › Bowie › NPI 1285182774
Clinic

Patient First Maryland Medical Group PLLC

Patient First Maryland Medical Group PLLC was paid $3.12M by Medicaid between Dec 2018 and Dec 2024, across 36 billing codes. Its largest line is S9083, Global fee urgent care centers — 55% of everything it billed.

33Billing provider infoPATIENT FIRST MARYLAND MEDICAL GROUP PLLC
BOWIE, MD 20715
33aNPI1285182774assigned 09/14/2016
28Total paid$3.12M
24GClaims68,575
24DCodes billed36
24AFirst – last monthDec 2018 – Dec 2024
Compared with peers

Next to other Urgent Care Clinic/Center providers in Maryland

Rank by total paid#32 of 114
Median peer was paid$654K
This provider vs. median4.8×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official MORISON, GEORGE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$50K$100K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201814$130.00
2019148$1K
20203,857$251K
202110,849$615K
202216,774$711K
202319,189$785K
2024incomplete17,744$756K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
S9083 Global fee urgent care centers 55% 13,027 11,123 $1.72M
S9088 Services provided in an urgent care center (list in addition to code for service) 21% 5,819 5,359 $643K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 8.5% 7,538 6,613 $266K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 7.3% 5,916 5,412 $229K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 2.8% 2,146 2,033 $89K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 2.7% 2,148 1,916 $83K
87428 1.3% 4,768 3,929 $40K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 1.1% 3,293 3,056 $33K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 565 508 $6K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 412 380 $2K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 5,686 4,968 $2K
99215 Doctor's office visit, returning patient (complex)Prolong outpt/office vis <1% 13 13 $1K
24 more codes
71046 Radiologic examination, chest; 2 views <1% 1,834 $1K
99058 <1% 125 $1K
A6449 Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard <1% 149 $1K
81000 <1% 1,870 $719.39
80047 <1% 1,660 $689.21
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 2,080 $603.41
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 2,111 $483.60
90686 <1% 35 $457.90
36415 Collection of venous blood by venipuncture <1% 2,296 $371.04
81002 <1% 1,799 $319.91
86580 <1% 15 $236.40
93000 <1% 450 $199.81
99201 <1% 28 $93.30
73564 <1% 46 $89.37
73610 <1% 70 $82.21
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 236 $68.65
81025 <1% 743 $58.90
87210 <1% 711 $37.70
87220 <1% 743 $31.67
73140 <1% 12 $25.19
99051 0% 123 $0.00
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) 0% 19 $0.00
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 0% 47 $0.00
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 0% 42 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMORISON, GEORGE (PRESIDENT)
Same official

Other billing entities under MORISON, GEORGE

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.